495 related articles for article (PubMed ID: 37185961)
41. Immunotherapy for advanced or metastatic urothelial carcinoma.
Maisch P; Hwang EC; Kim K; Narayan VM; Bakker C; Kunath F; Dahm P
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013774. PubMed ID: 37811690
[TBL] [Abstract][Full Text] [Related]
42. Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
Verhoef LM; van den Bemt BJ; van der Maas A; Vriezekolk JE; Hulscher ME; van den Hoogen FH; Jacobs WC; van Herwaarden N; den Broeder AA
Cochrane Database Syst Rev; 2019 May; 5(5):CD010455. PubMed ID: 31125448
[TBL] [Abstract][Full Text] [Related]
43. Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.
Blank O; von Tresckow B; Monsef I; Specht L; Engert A; Skoetz N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD007110. PubMed ID: 28447341
[TBL] [Abstract][Full Text] [Related]
44. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer.
Wagner AD; Thomssen C; Haerting J; Unverzagt S
Cochrane Database Syst Rev; 2012 Jul; (7):CD008941. PubMed ID: 22786517
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapy for advanced non-small cell lung cancer in the elderly population.
Santos FN; Castria TB; Cruz MR; Riera R
Sao Paulo Med J; 2016; 134(5):465-466. PubMed ID: 27901246
[TBL] [Abstract][Full Text] [Related]
46. Chemotherapy for advanced non-small cell lung cancer in the elderly population.
Santos FN; de Castria TB; Cruz MR; Riera R
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010463. PubMed ID: 26482542
[TBL] [Abstract][Full Text] [Related]
47. Extended-field radiotherapy for locally advanced cervical cancer.
Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
[TBL] [Abstract][Full Text] [Related]
48. Platinum-based chemotherapy for early triple-negative breast cancer.
Mason SR; Willson ML; Egger SJ; Beith J; Dear RF; Goodwin A
Cochrane Database Syst Rev; 2023 Sep; 9(9):CD014805. PubMed ID: 37681577
[TBL] [Abstract][Full Text] [Related]
49. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
[TBL] [Abstract][Full Text] [Related]
50. Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment.
Worthington HV; Bulsara VM; Glenny AM; Clarkson JE; Conway DI; Macluskey M
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD006205. PubMed ID: 37650478
[TBL] [Abstract][Full Text] [Related]
51. Convalescent plasma for people with COVID-19: a living systematic review.
Iannizzi C; Chai KL; Piechotta V; Valk SJ; Kimber C; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Jindal A; Cryns N; Estcourt LJ; Kreuzberger N; Skoetz N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013600. PubMed ID: 36734509
[TBL] [Abstract][Full Text] [Related]
52. Interventions for improving health literacy in migrants.
Baumeister A; Aldin A; Chakraverty D; Hübner C; Adams A; Monsef I; Skoetz N; Kalbe E; Woopen C
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD013303. PubMed ID: 37963101
[TBL] [Abstract][Full Text] [Related]
53. Colchicine for the treatment of COVID-19.
Mikolajewska A; Fischer AL; Piechotta V; Mueller A; Metzendorf MI; Becker M; Dorando E; Pacheco RL; Martimbianco ALC; Riera R; Skoetz N; Stegemann M
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015045. PubMed ID: 34658014
[TBL] [Abstract][Full Text] [Related]
54. The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.
Li X; Xu S; Tan Y; Chen J
Cochrane Database Syst Rev; 2015 Jun; (6):CD010432. PubMed ID: 26037486
[TBL] [Abstract][Full Text] [Related]
55. Immunotherapy for metastatic renal cell carcinoma.
Unverzagt S; Moldenhauer I; Nothacker M; Roßmeißl D; Hadjinicolaou AV; Peinemann F; Greco F; Seliger B
Cochrane Database Syst Rev; 2017 May; 5(5):CD011673. PubMed ID: 28504837
[TBL] [Abstract][Full Text] [Related]
56. PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer.
Roncolato F; Lindemann K; Willson ML; Martyn J; Mileshkin L
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD012160. PubMed ID: 31588998
[TBL] [Abstract][Full Text] [Related]
57. Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.
Chan DLH; Segelov E; Wong RS; Smith A; Herbertson RA; Li BT; Tebbutt N; Price T; Pavlakis N
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007047. PubMed ID: 28654140
[TBL] [Abstract][Full Text] [Related]
58. Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer.
Hoon SN; Lau PK; White AM; Bulsara MK; Banks PD; Redfern AD
Cochrane Database Syst Rev; 2021 May; 5(5):CD011220. PubMed ID: 34037241
[TBL] [Abstract][Full Text] [Related]
59. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Martinez-Zapata MJ; Martí-Carvajal AJ; Solà I; Pijoán JI; Buil-Calvo JA; Cordero JA; Evans JR
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008721. PubMed ID: 25418485
[TBL] [Abstract][Full Text] [Related]
60. Antiplatelet agents for the treatment of adults with COVID-19.
Fischer AL; Messer S; Riera R; Martimbianco ALC; Stegemann M; Estcourt LJ; Weibel S; Monsef I; Andreas M; Pacheco RL; Skoetz N
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD015078. PubMed ID: 37489818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
